Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Assessing Sex Differences in Metabolic Disease on Vasculopathy Using the Vascular Health Index
Nathaniel J Smail1, Lujaina Kamar1, Isabel Zimmerman1
1Departments of Medical Biophysics, University of Western Ontario, London, Ontario, USA.
Female rats show better vascular health with metabolic disease due to sex hormones. Ovariectomy removed this protection, highlighting hormone cycling
Area of Science:
- Cardiovascular Science
- Endocrinology
- Metabolic Disease Research
Background:
- Vascular health research often focuses on specific outcomes, hindering integrated status assessment.
- Understanding integrated vascular health across diverse risk conditions remains challenging.
- Quantifying sex-dependent differences in vascular health during metabolic disease is crucial.
Purpose of the Study:
- To quantify sex-dependent differences in peripheral and cerebral vascular health in metabolic disease.
- To investigate the role of sex hormones in protecting vascular health during metabolic disease.
Main Methods:
- Utilized the vascular health index (VHI) for simultaneous assessment of vascular reactivity, mechanics, and microvessel density.
- Compared male and female obese Zucker rats (OZR) with lean Zucker rats (LZR).
- Assessed VHI in ovariectomized (OVX) female OZR to determine the role of sex hormones.
Main Results:
- Obese male rats showed more rapid and severe decline in vascular health index (VHI) compared to obese female rats.
- Vascular health protection in obese female rats was dependent on intact sex hormone cycling.
- Ovariectomy (OVX) in female rats eliminated the protective effect on VHI.
Conclusions:
- Female rats exhibit sex-based protection in peripheral and cerebral vascular health during metabolic disease.
- This protection is mediated by normal female sex hormone cycling.
- Findings highlight the critical role of sex hormones in mitigating vascular complications of metabolic disease.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

